Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mellissa Williamson

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Oncology and Therapy|September 19, 2024
Real-World Study of the Burden of Myelodysplastic Syndromes in Patients and Their Caregivers in Europe and the United StatesKatie Lewis, Mellissa Williamson, Elliott Brown, et al.
Cancer Medicine|August 17, 2021
Front-line treatment patterns in multiple myeloma: An analysis of U.S.-based electronic health records from 2011 to 2019Shaji Kumar, Mellissa Williamson, Uzor Ogbu, et al.
Breast Cancer (Tokyo, Japan)|November 1, 2023
Population-level impact of adjuvant trastuzumab emtansine on the incidence of metastatic breast cancer: an epidemiological prediction model of women with HER2-positive early breast cancer and residual disease following neoadjuvant therapyMellissa Williamson, David J Press, Svenn Alexander Hansen, et al.
American Journal of Hematology|May 4, 2023
Clinical characteristics and overall survival among acute myeloid leukemia patients with TP53 gene mutation or chromosome 17p deletionNaval G Daver, Shahed Iqbal, Julie Huang, et al.
Pharmacoeconomics - Open|August 23, 2025
Identifying Potential Gaps in Care for Patients with Higher-Risk Myelodysplastic Syndromes in a Large US Health SystemKristin J Moore, Nicole M Engel-Nitz, Peter McMahon, et al.
Plos One|May 11, 2023
RWD-derived response in multiple myelomaTao Xu, James Roose, Mellissa Williamson, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Oncology and Therapy|September 19, 2024
Real-World Study of the Burden of Myelodysplastic Syndromes in Patients and Their Caregivers in Europe and the United StatesKatie Lewis, Mellissa Williamson, Elliott Brown, et al.
Cancer Medicine|August 17, 2021
Front-line treatment patterns in multiple myeloma: An analysis of U.S.-based electronic health records from 2011 to 2019Shaji Kumar, Mellissa Williamson, Uzor Ogbu, et al.
Breast Cancer (Tokyo, Japan)|November 1, 2023
Population-level impact of adjuvant trastuzumab emtansine on the incidence of metastatic breast cancer: an epidemiological prediction model of women with HER2-positive early breast cancer and residual disease following neoadjuvant therapyMellissa Williamson, David J Press, Svenn Alexander Hansen, et al.
American Journal of Hematology|May 4, 2023
Clinical characteristics and overall survival among acute myeloid leukemia patients with TP53 gene mutation or chromosome 17p deletionNaval G Daver, Shahed Iqbal, Julie Huang, et al.
Pharmacoeconomics - Open|August 23, 2025
Identifying Potential Gaps in Care for Patients with Higher-Risk Myelodysplastic Syndromes in a Large US Health SystemKristin J Moore, Nicole M Engel-Nitz, Peter McMahon, et al.
Plos One|May 11, 2023
RWD-derived response in multiple myelomaTao Xu, James Roose, Mellissa Williamson, et al.
Pageof 1